Literature DB >> 4159671

Heparin therapy in thromboembolic disease.

R J Kernohan, C Todd.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4159671     DOI： 10.1016/s0140-6736(66)90822-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

Review 1.  New anticoagulants for the treatment of venous thromboembolism.

Authors:  Caio Julio Cesar Dos Santos Fernandes; José Leonidas Alves Júnior; Francisca Gavilanes; Luis Felipe Prada; Luciana Kato Morinaga; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

2.  The economics of general thromboembolic prophylaxis.

Authors:  D Bergqvist; S Jendteg; B Lindgren; T Mätzsch; U Persson
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

Review 3.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Monitoring heparin therapy with the activated partial thromboplastin time.

Authors:  R K Stuart; A Michel
Journal:  Can Med Assoc J       Date:  1971-03-06       Impact factor: 8.262

5.  Total lung collapse after pulmonary infarction.

Authors:  S Aithan; J Khan; M Bazarbashi
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

6.  Prophylaxis of venous thromboembolism: analysis of cost effectiveness.

Authors:  E W Salzman; G C Davies
Journal:  Ann Surg       Date:  1980-02       Impact factor: 12.969

7.  Control of heparin therapy.

Authors:  W R Pitney; J E Pettit; L Armstrong
Journal:  Br Med J       Date:  1970-10-17

Review 8.  Antithrombotic drugs: part I.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 9.  Heparin therapy. Regimens and treatment considerations.

Authors:  T M Hyers
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

Review 10.  The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.

Authors:  Andrew D Blann; Chee W Khoo
Journal:  Vasc Health Risk Manag       Date:  2009-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.